Skip to main content
TRDA filings

Corporate insider profile

Ansbert Gadicke Filing Activity

Latest reported as Corporate insider of Entrada Therapeutics, Inc. (TRDA).

Purchase filings
0
Reported companies
1
Net open-market value
-$3,600,472.86
Latest transaction
Sep 9, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 9, 2026Entrada Therapeutics, Inc. (TRDA)Corporate insiderSale259,837$7.33$1,905,774
Sep 3, 2026Entrada Therapeutics, Inc. (TRDA)Corporate insiderSale86,482$7.14$617,378
Aug 31, 2026Entrada Therapeutics, Inc. (TRDA)Corporate insiderSale86,914$7.08$615,777